PacBio Announces Record Revenue in First Quarter 2023

MENLO PARK, Calif., May 2, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2023. First quarter results Revenue of $38.9 million, a 17% increase compared with $33.2 million in the prior year period. Shipped 38 sequencing systems…